Page last updated: 2024-09-04

pentacyanoferrate (ii) and Disease, Pulmonary

pentacyanoferrate (ii) has been researched along with Disease, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA1

Other Studies

1 other study(ies) available for pentacyanoferrate (ii) and Disease, Pulmonary

ArticleYear
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:2

    Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis

2012